Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability.
affective disorders
assessment
cognition
cognitive reserve
non-affective psychosis
psychosocial functioning
reliability
severe mental illness
validity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Apr 2019
28 Apr 2019
Historique:
received:
29
03
2019
revised:
18
04
2019
accepted:
25
04
2019
entrez:
1
5
2019
pubmed:
1
5
2019
medline:
1
5
2019
Statut:
epublish
Résumé
(1) Background: The cognitive reserve (CR) concept has not been precisely defined in severe mental disorders and has been estimated using heterogeneous methods. This study aims to investigate and develop the psychometric properties of the Cognitive Reserve Assessment Scale in Health (CRASH), an instrument designed to measure CR in people with severe mental illness; (2) Methods: 100 patients with severe mental illness (non-affective psychoses and affective disorders) and 66 healthy controls were included. The internal consistency and convergent validity of CRASH were assessed. Spearman's correlations coefficients were also performed to examine the relationship between CRASH and neuropsychological tests, psychosocial functioning, and clinical course; (3) Results: The internal consistency was high (Cronbach's alpha coefficient = 0.903). The CRASH global score had a large positive correlation with the Cognitive reserve questionnaire total score (
Identifiants
pubmed: 31035381
pii: jcm8050586
doi: 10.3390/jcm8050586
pmc: PMC6572583
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Psychiatry. 2015 Jun;2(6):483-5
pubmed: 26360429
Eur Neuropsychopharmacol. 2015 Feb;25(2):214-22
pubmed: 25172270
Psychol Med. 2007 Jul;37(7):1015-25
pubmed: 17112402
Am J Public Health. 2007 Oct;97(10):1756-7
pubmed: 17895405
Br J Psychiatry. 2016 Jan;208(1):87-93
pubmed: 26541692
Am J Psychiatry. 1992 Nov;149(11):1543-8
pubmed: 1415823
Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S69-74
pubmed: 16917199
World Psychiatry. 2016 Oct;15(3):288-289
pubmed: 27717267
Schizophr Bull. 2012 Jun;38(4):873-80
pubmed: 21389110
Psychiatry Res. 1994 Jul;53(1):31-40
pubmed: 7991730
Acta Psychiatr Scand. 2013 Sep;128(3):149-62
pubmed: 23617548
Psychol Med. 2016 Jan;46(2):291-301
pubmed: 26387583
Int J Neuropsychopharmacol. 2017 Aug 1;20(8):670-680
pubmed: 28498954
Front Psychiatry. 2018 Nov 29;9:641
pubmed: 30555363
Rehabil Res Pract. 2012;2012:386895
pubmed: 22966461
J Affect Disord. 2017 Jan 15;208:621-627
pubmed: 28029429
J Affect Disord. 2014 May;160:50-4
pubmed: 24709022
Med Clin (Barc). 2002 Sep 28;119(10):366-71
pubmed: 12372167
Psychol Med. 2000 Jan;30(1):205-17
pubmed: 10722191
Clin Pract Epidemiol Ment Health. 2007 Jun 07;3:5
pubmed: 17555558
Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13
pubmed: 17391354
Schizophr Res. 2017 Nov;189:84-90
pubmed: 28185786
Psychol Med. 2006 Aug;36(8):1053-64
pubmed: 16854246
Am J Geriatr Psychiatry. 2013 Mar;21(3):218-30
pubmed: 23395189
Psychol Med. 2008 Jun;38(6):771-85
pubmed: 17922938
Eur Neuropsychopharmacol. 2016 Oct;26(10):1638-48
pubmed: 27511320
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Schizophr Res. 2013 Jan;143(1):125-31
pubmed: 23182439
Aging Clin Exp Res. 2012 Jun;24(3):218-26
pubmed: 21691143
Rev Neurol. 2011 Feb 16;52(4):195-201
pubmed: 21312165
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Am J Psychiatry. 2002 Dec;159(12):2021-6
pubmed: 12450951
Med Clin (Barc). 2002 Apr 13;118(13):493-9
pubmed: 11975886
Acta Psychiatr Scand. 2018 Nov;138(5):441-455
pubmed: 30105820
Acta Psychiatr Scand. 2016 May;133(5):386-98
pubmed: 26719018
J Int Neuropsychol Soc. 2002 Mar;8(3):448-60
pubmed: 11939702
Schizophr Bull. 2011 Jul;37(4):768-77
pubmed: 19934212
Rev Psiquiatr Salud Ment (Engl Ed). 2019 Jan - Mar;12(1):1-8
pubmed: 30416047
PLoS One. 2014 Jul 22;9(7):e102632
pubmed: 25050711